Skip to content

No results found

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

PAVM PAVmed Inc. Common Stock
$10.10 0.00% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy PAVM stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 9.4M
Enterprise value 32.6M
Trailing PE 0.0870975
Forward PE -0.59649056
PEG Ratio -0.00037014998347654
Enterprise to EBITDA -1.63
Enterprise to revenue 1125.727
Price to book MRQ 0.92727274
Price to sales TTM 324.03818

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 29000
EBITDA -20034000
Diluted EPS TTM -12
Total Cash (MRQ) 3.4M
Current ratio (MRQ) 0.401
Operating Cash Flow (TTM) -3561000

PAVM trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent PAVM News

Home

No results found

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.